{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:44:14Z","timestamp":1789202654890,"version":"build-2803163510"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1151153"],"award-info":[{"award-number":["OPP1151153"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,7]]},"DOI":"10.1093\/cid\/ciy1122","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T22:33:10Z","timestamp":1546986790000},"page":"S83-S95","source":"Crossref","is-referenced-by-count":19,"title":["A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines"],"prefix":"10.1093","volume":"68","author":[{"given":"K","family":"Luthra","sequence":"first","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Watts","sequence":"additional","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Debellut","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pecenka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bar-Zeev","sequence":"additional","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-1584","authenticated-orcid":false,"given":"D","family":"Constenla","sequence":"additional","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"key\n\t\t\t\t2019030806461617900_CIT0001","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: A meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLOS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0002","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/S2214-109X(17)30328-5","article-title":"Updated estimates of typhoid fever burden in sub-Saharan Africa","volume":"5","author":"Kim","year":"2017","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0003","volume-title":"Background document: The diagnosis, treatment and prevention of typhoid fever","year":"2003"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0004","unstructured":"Sabin Vaccine Institute. First typhoid conjugate vaccine achieves WHO prequalification, a key step in protecting children and reducing the burden of typhoid 2018 Jan 3. Available at: http:\/\/www.coalitionagainsttyphoid.org\/first-typhoid-conjugate-vaccine-achieves-who-prequalification-a-key-step-in-protecting-children-and-reducing-the-burden-of-typhoid\/. Accessed January 30 2018."},{"key":"key\n\t\t\t\t2019030806461617900_CIT0005","year":"2017"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0006","unstructured":"World Health Organization. Typbar TCV\u00ae from Bharat Biotech, world\u2019s first typhoid conjugate vaccine prequalified by WHO [Press release]. Available at: http:\/\/www.who.int\/medicines\/news\/2017\/Bharat-Biotech-TypbarTCV-WHO-PQ-Press-Release-Global-Final.pdf?ua=1. Accessed January 30 2018."},{"key":"key\n\t\t\t\t2019030806461617900_CIT0007","year":"2016"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0008","first-page":"304","article-title":"Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy","volume":"22","author":"Bahl","year":"2004","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0009","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/infdis\/jix122","article-title":"Social and economic burden associated with typhoid fever in Kathmandu and surrounding areas: a qualitative study","volume":"218","author":"Kaljee","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-3156.2010.02711.x","article-title":"Cost of illness due to typhoid fever in five Asian countries","volume":"16","author":"Poulos","year":"2011","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0011","first-page":"377","article-title":"Cost of illness due to typhoid fever in Pemba, Zanzibar, East Africa","volume":"32","author":"Riewpaiboon","year":"2014","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0012","first-page":"725","article-title":"Treatment cost for typhoid fever at two hospitals in Kolkata, India","volume":"27","author":"Sur","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0013","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/21645515.2017.1333681","article-title":"A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions","volume":"13","author":"Mogasale","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0014","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2008.12.032","article-title":"An optimization model for reducing typhoid cases in developing countries without increasing public spending","volume":"27","author":"Lauria","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0015","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0016","first-page":"711","article-title":"Evaluating investments in typhoid vaccines in two slums in Kolkata, India","volume":"27","author":"Cook","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0017","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0018","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.vaccine.2015.02.027","article-title":"Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda","volume":"33","author":"Carias","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0019","first-page":"311","article-title":"A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community","volume":"22","author":"Poulos","year":"2004","journal-title":"J Health Popul Nutr"},{"issue":"Suppl 4","key":"key\n\t\t\t\t2019030806461617900_CIT0020","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/infdis\/jix598","article-title":"Comparison of strategies and incidence thresholds for Vi conjugate vaccines against typhoid fever: a cost-effectiveness modeling study","volume":"218","author":"Lo","year":"2018","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030806461617900_CIT0021","article-title":"Forecasting demand for the typhoid conjugate vaccine in low- and middle-income countries","author":"Debellut","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_2\/S83\/28024029\/ciy1122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T06:59:24Z","timestamp":1552028364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_2\/S83\/5371234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":21,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,3,7]]},"published-print":{"date-parts":[[2019,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1122","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2019,3,7]]}}}